FENU, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 112.379
NA - Nord America 5.881
AS - Asia 598
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 4
AF - Africa 3
OC - Oceania 3
Totale 118.876
Nazione #
IT - Italia 110.507
US - Stati Uniti d'America 5.837
UA - Ucraina 695
CN - Cina 520
SE - Svezia 373
DE - Germania 335
FI - Finlandia 161
GB - Regno Unito 159
FR - Francia 57
CA - Canada 40
RU - Federazione Russa 36
SG - Singapore 32
IN - India 18
BE - Belgio 17
ES - Italia 8
EU - Europa 8
IR - Iran 8
IE - Irlanda 6
NL - Olanda 6
PL - Polonia 6
CZ - Repubblica Ceca 5
VN - Vietnam 4
AU - Australia 3
CO - Colombia 3
IL - Israele 3
MX - Messico 3
EG - Egitto 2
JP - Giappone 2
KR - Corea 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 118.876
Città #
Cagliari 110.199
Fairfield 764
Woodbridge 711
Chandler 561
Houston 436
Ann Arbor 406
Ashburn 392
Jacksonville 376
Wilmington 352
Seattle 306
Nyköping 272
Cambridge 248
Dearborn 157
Boardman 140
Nanjing 117
Boston 83
Beijing 60
Helsinki 56
Shanghai 46
Milan 41
San Diego 41
Shenyang 38
New York 36
Guangzhou 33
Nanchang 32
Toronto 32
Hebei 30
Redwood City 30
Changsha 26
Jiaxing 25
Norwalk 25
Verona 25
Tianjin 20
Mountain View 17
Brussels 16
Auburn Hills 14
Los Angeles 14
London 13
Orange 13
Washington 13
Kunming 12
Upgant-schott 12
Ningbo 11
Augusta 10
Zhengzhou 10
Hangzhou 9
Jinan 9
San Mateo 9
Saint Petersburg 8
Ardabil 7
Chicago 7
Hefei 7
Assèmini 6
Atlanta 6
Renton 6
Sassari 6
Taizhou 6
Walnut 6
Modrice 5
Naples 5
Rome 5
Tappahannock 5
Dong Ket 4
Falls Church 4
Indiana 4
Kilburn 4
Mumbai 4
Nürnberg 4
Quartu Sant'Elena 4
Rockville 4
Borås 3
Cedar Knolls 3
Chengdu 3
Detroit 3
Dublin 3
Gurgaon 3
Ionadi 3
Leawood 3
Monmouth Junction 3
Neiva 3
Simi Valley 3
Xian 3
Anguillara 2
Baotou 2
Belfast 2
Frankfurt am Main 2
Fulda 2
Fuzhou 2
Langhorne 2
Louisville 2
Mexico City 2
Millbury 2
New Bedfont 2
North York 2
Perugia 2
Pisa 2
Prescot 2
Pune 2
Redmond 2
San Francisco 2
Totale 116.487
Nome #
null 4.110
Acquisition and expression of conditioned taste aversion differentially affects extracellular signal regulated kinase and glutamate receptor phosphorylation in rat prefrontal cortex and nucleus accumbens 4.086
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation 3.675
Caffeine and the brain: an overview 3.441
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.357
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.121
Behavioural pharmacology of caffeine 2.898
Evaluation of rewarding properties of pramipexole in a rat model of Parkinson’s disease: role of genetic background 2.868
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 2.650
Behavioral Pharmacology of Caffeine 2.620
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: behavioral and biochemical study 2.606
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function 2.555
In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors 2.513
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: a behavioral and biochemical study 2.438
L dopa chronic treatment increases reactive microglia and tnf- alpha production in the 6-ohda lesioned striatum 2.436
Adolescent Cannabis exposure differentially affects heroin reinforcement and accumbens dopamine transmission in Lewis and Fischer344 rats 2.242
null 2.160
null 2.148
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.144
Possibile ruolo dei recettori 5-HT6 nelle dipendenze 2.110
Conditioned Saccharine Avoidance induced by intra-Accumbens shell amphetamine and intra-VTA morphine 2.045
Conditioned Saccharine Avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area 2.017
Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement 1.963
Influence of strain and age on voluntarily ethanol intake and on GAD-67 expression in the central amygdala 1.953
Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression 1.901
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions 1.827
null 1.797
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain 1.659
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.592
Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 1.580
null 1.580
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age 1.539
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant? 1.442
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS? 1.416
Controversie: Priming dopaminergico nel Parkinson. Il "priming" come modello sperimentale delle discinesie indotte da terapie dopaminergiche sostitutive nella Malattia di Parkinson 1.299
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.109
Effects of QO-IIR, a new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural, neurochemical and immunoistochemical study 1.093
Caffeine potentiates 3,4 methylenedioxymethamphetamine (MDMA, ecstasy)-induced-glial activation: role of age and adenosine A1 and A2A receptors 1.034
Differential involvement of dopamine D1 receptors in morphine- and lithium- conditioned saccharin avoidance 960
Role of Adenosine A1 and A2A receptors on 3,4-methylendioxymeth-amphetamine (MDMA, Ecstasy)-induced neurotoxicity, astroglia and microglia reactivity in mouse striatum and substantia nigra 929
null 801
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease 776
A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning 770
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 767
Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats 715
Conditioned saccharin avoidance and sensitization to drugs of abuse 702
Effetto del blocco dei recettori oppioidi delta sul turning controlaterale indotto dagli agonisti dopaminergici in ratti lesionati con la 6-idrossidopamina 671
Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses 634
Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson’s disease 629
Effect of MK 801 on priming of D-1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen 620
Modulation of dopamine d1-mediated turning behavior and striatal c-fos expression by the substantia nigra 612
Conditioned saccharin avoidance and sensitization to drugs of abuse 611
null 594
Blockade of pallidal adenosine A2A receptors potentiates contralateral rotational behavior induced by L-DOPA and dopaminergic agonists in hemiparkinsonian rats 592
“Priming” to dopamine agonist-induced contralateral turning as model of non associative sensitization to the expression of the post-synaptic dopamine message 591
null 580
Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors 576
Effect of delta opioid receptors blockade on turning behavior induced by dopamine agonists in unilaterally 6-hydroxydopamine lesioned rats 556
Accumbens shell dopamine and stimulus-reward learning 552
Different involvement of Dopamine D1 receptor in morphine and lithium conditioned saccharin avoidance 547
Adenosine A2 Receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats 520
null 515
Different involvement of dopamine D1 receptor in morphine- and lithium-induced conditioned saccharin avoidance 511
Changes in GAD67 and peptides mRNA levels in specific populations of striatal efferent neurons following priming with dopamine agonists in 6-OHDA lesioned rats 511
Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of parkinsonism: role of priming 505
null 504
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 501
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 500
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. 496
null 479
Alterazioni nei livelli striatali di RNAm della GAD67, dinorfina e enkefalina, in seguito a priming con agonisti dopaminergici nel modello di morbo di parkinson della 6-ohda 475
Differential effect of priming with dopamine agonists on mrna for GAD-67, dynorphin and enkephalin in 6-OHDA lesioned rats 471
Opposite effects of nmda receptor blockade on dopaminergic d1-mediated and d2-mediated behavior in the 6-hydroxydopamine model of turning - relationship with c-fos expression 471
Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors. 471
Differential role of dopamine in drug- and lithium conditioned saccharin avoidance 466
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 438
null 425
‘Priming’ phenomena in the expression of D1 and D2 receptor supersensitivity 420
Modulation of turning behavior induced by dopamine D1 agonists in 6-hydroxydopamine lesioned rats by intranigral infusion of glutamate antagonists. 388
Opposite effects of NMDA receptor blockade on dopaminergic D1 and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression 382
Nicotine-conditioned single–trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 380
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 374
The influence of priming on the behavioral expression of dopamine receptor supersensitivity in basal ganglia 365
Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance 363
Priming of the behavioral expression of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 338
Priming of the behavioral of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 338
Blockade of NMDA receptors differentially affects D1 and D2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson 322
Motor stimulant effects of caffeine in 6-hydroxydopamine lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors 302
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 295
Disruption of latent inhibition in a conditioned taste aversion paradigm by D1 receptor blockade: role of dopamine in consolidation of gustatory memory traces 281
Facilitation of conditioned taste aversion learning by systemic amphetamine: role of nucleus accumbens shell dopamine D1 receptors 281
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats 275
null 274
Effects of QO-IIR, a COMT inhibitor, in two experimental animal models of parkinson's disease: behavioral and immunohistochemical study 265
Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors 263
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors 258
Selective adenosine A2A receptor antagonists suppress jaw movements in the rat tacrine model of parkinsonian tremor 245
Dissociation of dopamine D1-induced turning behaviour and D1-induced increases in striatal acetylcholine release in 6-OHDA lesioned rats 234
CONDITIONED TASTE AVERSION ELICITED ERK ACTIVATION AND CHANGES OF DENDRITIC SPINES DENSITY: AN IMMUNOHISTOCHEMICAL, GOLGI-COX AND ELECTRON MICROSCOPY STUDY 231
Dopamine and drug addiction: the nucleus accumbens shell connection 228
Totale 115.170
Categoria #
all - tutte 142.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.228 0 0 0 0 0 0 0 0 0 0 753 475
2019/202022.877 1.232 869 128 480 8.439 5.203 3.200 765 540 614 668 739
2020/202129.742 1.204 1.119 1.548 8.093 6.055 3.328 3.018 1.521 557 1.218 1.064 1.017
2021/20225.302 677 488 276 417 493 326 251 265 507 566 547 489
2022/20237.785 624 961 1.037 665 565 767 427 687 556 582 632 282
2023/20248.956 502 1.523 597 805 999 1.433 1.135 834 369 660 99 0
Totale 119.102